Kinase inhibitors for the treatment of inflammatory and autoimmune disorders |
| |
| Authors: | Shripad S Bhagwat |
| |
| Affiliation: | (1) Ambit Biosciences, 4215 Sorrento Valley Boulevard, San Diego, CA 92121, USA |
| |
| Abstract: | Drugs targeting inhibition of kinases for the treatment of inflammation and autoimmune disorders have become a major focus in the pharmaceutical and biotech industry. Multiple kinases from different pathways have been the targets of interest in this endeavor. This review describes some of the recent developments in the search for inhibitors of IKK2, Syk, Lck, and JAK3 kinases. It is anticipated that some of these compounds or newer inhibitors of these kinases will be approved for the treatment of rheumatoid arthritis, psoriasis, organ transplantation, and other autoimmune diseases. |
| |
| Keywords: | Kinase inhibitors Anti-inflammatory agents Autoimmune modulators IKK2 inhibitors Syk inhibitors Lck inhibitors JAK3 inhibitors |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
